Tarbox Family Office’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-805
| Closed | -$12K | – | 876 |
|
|
2022
Q1 | $12K | Hold |
805
| – | – | ﹤0.01% | 364 |
|
|
2021
Q4 | $11K | Hold |
805
| – | – | ﹤0.01% | 449 |
|
|
2021
Q3 | $13K | Hold |
805
| – | – | ﹤0.01% | 453 |
|
|
2021
Q2 | $14K | Hold |
805
| – | – | ﹤0.01% | 438 |
|
|
2021
Q1 | $15K | Hold |
805
| – | – | ﹤0.01% | 369 |
|
|
2020
Q4 | $15K | Hold |
805
| – | – | ﹤0.01% | 350 |
|
|
2020
Q3 | $14K | Hold |
805
| – | – | ﹤0.01% | 339 |
|
|
2020
Q2 | $14K | Hold |
805
| – | – | ﹤0.01% | 334 |
|
|
2020
Q1 | $12K | Hold |
805
| – | – | ﹤0.01% | 308 |
|
|
2019
Q4 | $16K | Hold |
805
| – | – | ﹤0.01% | 306 |
|
|
2019
Q3 | $14K | Hold |
805
| – | – | ﹤0.01% | 292 |
|
|
2019
Q2 | $14K | Hold |
805
| – | – | ﹤0.01% | 289 |
|
|
2019
Q1 | $16K | Buy |
+805
| New | +$16K | 0.01% | 253 |
|